Global Pharmerging Market Analysis, Trends, and Forecasts, 2019-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Pharmerging - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Pharmerging market worldwide is projected to grow by US$780.7 Million, driven by a compounded growth of 10.9%.

Pharmaceutical, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$936.2 Million by the year 2025, Pharmaceutical will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$35.7 Million to the region's size and clout in the next 5 to 6 years. Over US$36.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pharmaceutical will reach a market size of US$69.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$133.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • AbbVie, Inc.
  • Alexion Pharmaceuticals, Inc.
  • Allergan PLC
  • Amgen, Inc.
  • Aspen Pharmacare Holdings Ltd.
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Bayer AG
  • Biogen, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • CSL Behring
  • Daiichi Sankyo Co., Ltd.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Endo International PLC
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Grifols SA
  • H. Lundbeck A/S
  • Hospira, Inc.
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • Mallinckrodt Pharmaceuticals
  • Mitsubishi Tanabe Pharma Corporation
  • Mylan Pharmaceutical Pvt. Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer, Inc.
  • Sanofi SA
  • Shire PLC
  • Stada Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Pharmerging Market to Grow Steadily, Driven by Rapid Growth of the Pharma Sector
  • Worldwide Pharmaceutical Market Growth Projections by Regional Group: 2018 and 2022
  • Breakdown of Growth Percentage and Spending in Billion USD for Pharmerging Markets by Country: 2007-2022
  • Global Competitor Market Shares
  • Pharmerging Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Pharmaceutical Segment to Register Strong Growth
  • Total Spending on Medicines (in Billion USD) in Select Emerging Pharmaceutical Markets: 2023
  • Healthcare Market in Tier I Pharmerging Region (USD Billion) by Product: 2014-2025
  • Asia-Pacific Region to Retain Top Slot

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Geriatric Population to Bode Well for Market Growth
  • Total Breakdown of People Aged Over 60 by Development Groups: 1980 to 2050
  • Increase in Patient Numbers to Support Market Growth
  • Top Therapeutic Areas by Spending (Billion USD) in Pharmerging Markets: 2018
  • Select Therapy Areas Spending (Billion USD) in Pharmerging Markets: 2020
  • Increasing Preference for Generics to Spur Market Expansion

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
  • US Pharmerging Market Share (in %) by Company: 2019 & 2025
  • Market Analytics

CANADA

JAPAN

CHINA

EUROPE

  • Market Facts & Figures
  • European Pharmerging Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/licn5t

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900